High levels of both iNAMPT and visfatin/eNAMPT were expressed in BRAFi-resistant melanoma cells, while transcriptional downregulation of NAMPT was reported in BRAFi-sensitive cells (57–59). The gene discussed is NAMPT; the disease is melanoma.